Renaissance Capital logo

Longview Acquisition II Priced, NYSE: LGV

Second blank check company formed by executives at healthcare-focused hedge fund Glenview Capital (liquidated).

Industry: SPAC

Latest Trade: $10.09 0.00 (0.0%)

First Day Return: +0.1%

Return from IPO: +0.9%

Industry: SPAC

We are a newly organized blank check company. Our sponsor is an affiliate of Glenview Capital Management, LLC (“Glenview Capital Management” or “Glenview”), a registered investment adviser with investment experience and a track record of creating value through constructive partnerships with companies operating in the public markets. We intend to focus on private businesses where we believe that their management, with our assistance, can execute a plan to create value for our stockholders in the public markets. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on the industries that align with the background of the sponsor with a particular emphasis placed on the healthcare sector. These industries include healthcare, industrials, consumer, media, technology and technology services. We will seek to acquire established businesses that we believe are fundamentally sound but potentially in need of financial, operational, or strategic assistance to maximize value.
more less
IPO Data
IPO File Date 01/29/2021
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 60.0
Deal Size ($mm) $600
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 03/18/2021
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 60.0
Deal Size ($mm) $600
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
UBS Investment Bank
TD Cowen
Company Data
Headquarters New York, NY, United States
Founded 2020
Employees 3

Longview Acquisition II (LGV) Performance